openPR Logo
Press release

Treatment Options For Global Gastric Cancer Market: Surgery, Chemotherapy, Radiotherapy And Targeted Therapy

11-21-2017 11:57 AM CET | Health & Medicine

Press release from: Gastric Cancer

Market Research Report

Market Research Report

Researchmoz added Most up-to-date research on "Treatment Options For Global Gastric Cancer Market: Surgery, Chemotherapy, Radiotherapy And Targeted Therapy" to its huge collection of research reports.

Cancer is a condition where an error or mutation in the cell’s DNA occurs, causing it to grow at a rapid rate. A cancer cell continues living while a normal cell would die, thus, accumulating to form a tumor that can break off and spread throughout the body. Gastric cancer is when such a condition occurs in the stomach and has the tendency to grow through the wall of the stomach to invade nearby organs including lymph nodes and lymph vessels. There are four types of cancers of the stomach namely, Adenocarcinoma, Lymphoma, Gastrointestinal stromal tumor (GIST), Carcinoid tumor and others such as squamous cell carcinoma, small cell carcinoma, and leiomyosarcomat that can start in the stomach, but are very rare.

The causes of stomach cancer are rather unclear in medical study; however, there is a strong correlation between a diet high in smoked, salted and pickled foods, obesity and ageing. People with Helicobacter infections are also highly prone to gastric cancer. Symptoms of gastric cancer may include, fatigue, feeling bloated after eating, severe heartburn and indigestion, stomach pain, persistent and unexplained vomiting and nausea, unintentional weight loss, belching, anemia, and persistent ulcer. Its medical diagnosis techniques involve upper endoscopy, imaging tests and exploratory surgery. Treatment options include surgery, chemotherapy, radiotherapy and targeted therapy.

To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=728193

Global gastric cancer market is conspicuous by poor prognosis, because of the indolent nature of the disease. However, better diagnostic technology and shifting treatment market from chemotherapy to targeted therapies is expected to warrant positive growth in the years ahead. Rising oncology drug spending, ageing population, increasing obese population and rising global male population are expected to drive this growth. Certain trends in the global gastric cancer market include, a healthy pipeline of combinations targeted therapies, shifting focus towards molecular targeted therapies, and keen interest in eradication H. Pylori infection across the globe. The market is however, afflicted by certain challenges like low penetration of new targeted therapies and lack of reimbursement of cancer drugs.

The report provides an overview of the entire market through global and regional analysis. Prevalence and market value of gastric cancer across the globe and that of its various types and stages including advanced, her2 positive, stage III and metastatic gastric cancer have been analyzed.

Browse TOC @ https://www.researchmoz.us/global-gastric-cancer-market-report-2016-edition-report.html/toc

Table of Content

1. Market Overview
1.1 Introduction
1.2 Types
1.3 Stages
1.4 Causes & Prevention
1.5 Diagnosis
1.5.1 Symptoms
1.5.2 Medical Diagnosis
1.6 Treatment Options
1.6.1 Surgery
1.6.2 Chemotherapy
1.6.3 Radiotherapy
1.6.4 Targeted Therapy

2. Global Market
2.1 Global Gastric Cancer Market by Prevalence
2.2 Global Advanced Gastric Cancer Market by Value

3. Regional Markets
3.1. The U.S.
3.1.1 The U.S. Gastric Cancer Market by Prevalence
3.1.2 The U.S. Her 2+ Gastric Cancer Prevalence
3.1.3 The U.S. Stage III Gastric Cancer Prevalence
3.1.4 The U.S. Advanced Gastric Cancer Market by Prevalence
3.1.5 The U.S. Advanced Gastric Cancer Market by Value
3.1.6 The U.S. Metastatic Gastric Cancer Prevalence

About ResearchMoz

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

Mr. Nachiket
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Email: sales@researchmoz.us
Website @ http://www.researchmoz.us/
Tel: 866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-621-2074
Follow us on LinkedIn @ http://bit.ly/1TBmnVG

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Treatment Options For Global Gastric Cancer Market: Surgery, Chemotherapy, Radiotherapy And Targeted Therapy here

News-ID: 826296 • Views:

More Releases from Gastric Cancer

Treatment Options Available For Global Gastric Cancer Market: Surgery, Chemotherapy, Radiotherapy And Targeted Therapy
Treatment Options Available For Global Gastric Cancer Market: Surgery, Chemother …
Researchmoz added Most up-to-date research on "Treatment Options Available For Global Gastric Cancer Market: Surgery, Chemotherapy, Radiotherapy And Targeted Therapy" to its huge collection of research reports. Cancer is a condition where an error or mutation in the cell’s DNA occurs, causing it to grow at a rapid rate. A cancer cell continues living while a normal cell would die, thus, accumulating to form a tumor that can break off and
Global Gastric Cancer Industry Key Trends, Size, Growth, Shares And Forecast Res …
Researchmoz added Most up-to-date research on "Global Gastric Cancer Market Report: 2016 Edition" to its huge collection of research reports. Cancer is a condition where an error or mutation in the cell’s DNA occurs, causing it to grow at a rapid rate. A cancer cell continues living while a normal cell would die, thus, accumulating to form a tumor that can break off and spread throughout the body. Gastric cancer is
Research of Gastric Cancer Therapeutics in Asia-Pacific : Share, Trends and Appl …
ALBANY, NY, FEB 28, 2017 : Gastric cancer is characterized by the formation of malignant cells in the inner lining of the stomach and is the fifth-most common cancer globally. There are many types of gastric cancer, but adenocarcinoma is the most common type and is diagnosed in 95% of cases. The life expectancy and survival rate for gastric cancer is heavily dependent on the stage of the disease when

All 4 Releases


More Releases for Prevalence

Myasthenia Gravis Market | Rising Prevalence Of Neuromuscular Disorders
According to Precision Business Insights (PBI), the latest report, the Myasthenia Gravis market is expected to be valued at USD 1,734.6 million in 2022, growing at an 8.1% CAGR from 2022 to 2028. The primary driver of the expansion of the global Myasthenia Gravis market increasing prevalence of neuromuscular disorders, and rising awareness about effective treatment. View the detailed report description here - https://precisionbusinessinsights.com/market-reports/myasthenia-gravis-market/ Medication Segment to Dominate the Myasthenia
Microtome Market Rising Prevalence of Cancer
Microtome is a device used for sample preparation in laboratories. The devices are used to slice biological specimens into evenly thin sections for a detailed microscopic examination. The microtome market is expected to witness huge growth during the forecast period on the back of the rising prevalence of cancer and increasing adoption of digital pathology. Moreover, growing focus on personalized medicine is further expected to foster the market growth in
Rising Cancer Prevalence Driving Molecular Cytogenetics Market Growth
The increasing cases of cancer, usage of pharmacogenomics for drug development and disease management, enhancements in molecular cytogenetics and its expanding application in agriculture, requirement for predicting chromosomal abnormalities based on genes, and surging geriatric population are driving the usage of molecular cytogenetics. From $1.8 billion in 2017, the molecular cytogenetics market is projected to reach $3.3 billion by 2023, at a 9.9% CAGR during 2018-2023 (forecast period). The term
Clear Aligners Market: Growing Prevalence of Dental Problems
Dental and oral conditions affect people once in their lifetime. A single toothache causes discomfort, pain, and disfigurement. As per the Global Burden of Diseases Study in 2016, oral diseases have affected approximately 3.58 billion people across the world. Dental diseases include dental caries. The prevalence of dental and oral conditions is rising across the region, such as crooked teeth, overbites, underbites, crossbites, spaces between teeth, teeth overcrowding, and the
Rising prevalence of Neuroprosthetics Market 2017-2021
"The Report Global Neuroprosthetics Market 2017-2021 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" About Neuroprosthetics The neural prosthetics systems rely on the detection and processing of brain activity involved in the planning and execution of movement intentions. Neuroprosthetics are used for individuals suffering an amputation as it restores the damaged motor, sensory, and autonomic functions by stimulating various parts of the nervous
Global Cataract Surgery Device Market: Increasing Prevalence, Increasing Advance …
Market Synopsis of Cataract Surgery device Market: Market Scenario: The globally market for cataract surgery device is growing steadily. Factors that influence the cataract surgery device market are increasing prevalence of cataract surgery, increasing advance technology in cataract surgery device market, increase in the aging population, prevalence of eye disease and many others. Globally the market for cataract surgery device is expected to grow at the rate of about 5.5% from 2016